Pacific Beach BioSciences Licenses Novel Fluoroquinolone From Korean Firm Dong Wha
This article was originally published in The Pink Sheet Daily
Executive Summary
San Diego start-up will develop zabofloxacin for community acquired respiratory infections.
You may also be interested in...
J&J’s Levaquin Gets FDA Approval For Pyelonephritis, Complicated UTIs
Once-daily oral levofloxacin approved for high-dose, short-course treatment of complicated UTI and pyelonephritis.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.